Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00396006
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2006-11-03
Brief Title:
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 Human Alpha 1 - Proteinase Inhibitor
Sponsor:
Baxalta now part of Shire
Organization:
Takeda
Organization Data
Organization:
Takeda
Class:
INDUSTRY
Study ID:
460502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Baxalta now part of Shire
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None